Skip to content

Clinical trials

Phase 3 Dyslipidemias trials in Germany

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Dyslipidemias Phase: Phase 3 Country / region: Germany Clear all

28 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20041
20053
200612
20072
20091
20121
20131
20141
20172
20231
20241
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed22
Terminated4
Recruiting2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Takeda9
Kowa Research Europe6
Amgen3
Novartis Pharmaceuticals2
89bio, Inc.1
Abbott1
Amarin Pharma Inc.1
Boehringer Ingelheim1
GWT-TUD GmbH1
Kowa Research Institute, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Dyslipidemias28
Diabetes Mellitus, Type 210
Glucose Metabolism Disorders9
Hypercholesterolemia9
Diabetes Mellitus8
Hyperlipidemias5
Aortic Valve Stenosis2
Cardiovascular Diseases2
Diabetes Mellitus, Lipoatrophic2
Heart Failure2

Trials

Showing 1 to 25 of 28. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.